Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study

Official Title: Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study

This pilot study aims to assess the safety and treatment effect of acute dosing with IV Remodulin in neonates with persistent pulmonary hypertension of the newborn (PPHN).

ClinicalTrials.gov ID: NCT02261883

Principal Investigator: Porta, Nicolas F., MD

Study Type: Interventional

Currently Recruiting Patients: Yes

Contact Information:

Molly Schau, RN

Research Nurse

312.227.5024

Specialties & Conditions

Patients & Visitors

Plan Your Visit

While You're Here

After Your Visit

Research Innovation

Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study

Official Title: Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study

Contact Information:

Find

Get in Touch

Get to Know Us

For Healthcare Professionals